Hand foot and mouth disease, from emergence to vaccine control

Journal of Vaccines and Vaccination

Volumn 4, Issue 5, 2013, Pages

  Ibrahim, Shady Mahmoud Attia ^a   Kamel, Mohamed Ismail ^b   Elsaie, Mohamed L ^c  

^a AL AZHAR UNIVERSITY   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880778594     PISSN: None     EISSN: 21577560     Source Type: Journal    
DOI: 10.4172/2157-7560.1000191     Document Type: Article

References (7)

1. Kadurugamuwa JL, Shaheen E (2011) Inactivation of human enterovirus 71 and coxsackie virus A16 and hand, foot, and mouth disease. Am J Infect Control 39: 788-789.
2. Wong SS, Yip CC, Lau SK, Yuen KY (2010) Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect 138: 1071-1089.
3. Chang JY, Chang CP, Tsai HH, Lee CD, Lian WC, et al. (2012) Selection and characterization of vaccine strain for Enterovirus 71 vaccine development. Vaccine 30: 703-711.
4. Sarma N (2013) Hand, foot, and mouth disease: current scenario and Indian perspective. Indian J Dermatol Venereol Leprol 79: 165-175.
5. Lee MS, Chang LY (2010) Development of enterovirus 71 vaccines. Expert Rev Vaccines 9: 149-156.
6. Chong P, Hsieh SY, Liu CC, Chou AH, Chang JY, et al. (2012) Production of EV71 vaccine candidates. Hum Vaccin Immunother 8.
7. Zhu FC, Meng FY, Li JX, Li XL, Mao QY, et al. (2013) Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 381: 2024-2032.